Jennifer Gunter
Dr. Jennifer Gunter (PhD) joined Australian Prostate Cancer Research Centre – Queensland from a metabolic research background spanning 10 years to focus on the intersection between chronic metabolic disorders and their emerging relationship to prostate cancer. She has contributed to research demonstrating links between elevated insulin and related growth factors, associated with androgen deprivation with prostate cancer progression. Dr. Gunter’s primary research is aimed at understanding how metabolic syndrome induced by ADT contributes to CRPC, in particular whether insulin-lowering metabolic therapies, including metformin, may be useful as adjuvant therapies in advanced prostate cancer.
Abstracts this author is presenting:
